# Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection

> clinical trial · VERIFIED · 2026-08-18

Status: ACTIVE_NOT_RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Cytomegaloviral Infection

- Company: M.D. Anderson Cancer Center
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT02210078

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.